anonymous
Guest
anonymous
Guest
Great data presented to take back the market. We won’t lose Trulicity scripts to Ozempic now that we basically match A1c and are right there in weight loss.
Preferred device, better covered and same clinical profile. That’s a win for us!!!
Preferred device, better covered and same clinical profile. That’s a win for us!!!